Low serum 25-hydroxyvitamin D levels are associated with increased cardiovascular morbidity and mortality

References

• Delos RJ, Smyth A, Griffin D, et al. Vitamin D deficiency and insufficiency prevalence in the west of Ireland-A retrospective study. The Journal of Nutrition, Health & Aging. 2017;21(10):1107–1110.
   PubMed Web of Science ®Google Scholar
• Yousef S, Elliott J, Manuel D, et al. Study protocol: worldwide comparison of vitamin D status of immigrants from different ethnic origins and native-born populations—a systematic review and meta-analysis. Syst Rev. 2019;8(1):211.
   PubMed Web of Science ®Google Scholar
• Celermajer DS, Chow CK, Marijon E, et al. Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J Am Coll Cardiol. 2012;60(14):1207–1216.
   PubMed Web of Science ®Google Scholar
• Haddad JG, Hahn TJ. Natural and synthetic sources of circulating 25-hydroxyvitamin D in man. Nature. 1973;244(5417):515–517.
   PubMed Web of Science ®Google Scholar
• Zhang R, Li B, Gao X, et al. Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies. Am J Clin Nutr. 2017;105(4):810–819.
   PubMed Web of Science ®Google Scholar
• Mokhtari E, Hajhashemy Z, Saneei P. Serum Vitamin D levels in relation to hypertension and pre-hypertension in adults: a systematic review and dose-response meta-analysis of epidemiologic studies. Front Nutr. 2022;9:829307.
   PubMed Web of Science ®Google Scholar
• Forouhi NG, Ye Z, Rickard AP, et al. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European prospective investigation into cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. DIABETOLOGIA. 2012;55(8):2173–2182.
   PubMed Web of Science ®Google Scholar
• Muñoz A, Grant WB. Vitamin D and cancer: an historical overview of the epidemiology and mechanisms. Nutrients. 2022;14(7):1448.
   Web of Science ®Google Scholar
• Weldegiorgis TZ, Hidru TH, Xiao-Lei Y, et al. Association between serum 25-hydroxyvitamin D concentrations and metabolic syndrome in the middle-aged and elderly Chinese population in Dalian, northeast China: a cross-sectional study. J Diabetes Invest. 2020;11(1):184–191.
   PubMed Web of Science ®Google Scholar
• Heath AK, Hodge AM, Ebeling PR, et al. Circulating 25-hydroxyvitamin D concentration and cause-specific mortality in the Melbourne collaborative cohort study. J Steroid Biochem Mol Biol. 2020;198:105612.
   PubMed Web of Science ®Google Scholar
• Gholami F, Moradi G, Zareei B, et al. The association between circulating 25-hydroxyvitamin D and cardiovascular diseases: a meta-analysis of prospective cohort studies. BMC Cardiovasc Disord. 2019;19(1):248.
   PubMed Web of Science ®Google Scholar
• Mao F, Jiang Y, Liu J, et al. Geographic variation in cardiovascular health as analyzed from the China cardiovascular health index study - 31 PLADs, China, 2017-2021. China CDC Weekly. 2022;4(13):265–270.
   PubMedGoogle Scholar
• Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American heart association. CIRCULATION. 2011;123(8):933–944.
   PubMed Web of Science ®Google Scholar
• Durup D, Jørgensen HL, Christensen J, et al. A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality: the CopD study. J Clin Endocrinol Metab. 2015;100(6):2339–2346.
   PubMed Web of Science ®Google Scholar
• Swart KM, Lips P, Brouwer IA, et al. Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials. Am J Clin Nutr. 2018;107(6):1043–1053.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. CIRCULATION. 2008;117(4):503–511.
   PubMed Web of Science ®Google Scholar
• Ginde AA, Scragg R, Schwartz RS, et al. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc. 2009;57(9):1595–1603.
   PubMed Web of Science ®Google Scholar
• Pilz S, Dobnig H, Nijpels G, et al. Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf). 2009;71(5):666–672.
   PubMed Web of Science ®Google Scholar
• Melamed ML, Michos ED, Post W, et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629–1637.
   PubMed Web of Science ®Google Scholar
• Cawthon PM, Parimi N, Barrett-Connor E, et al. Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J Clin Endocrinol Metab. 2010;95(10):4625–4634.
   PubMed Web of Science ®Google Scholar
• Jassal SK, Chonchol M, von Mühlen D, et al. Vitamin d, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study. Am J Med. 2010;123(12):1114–1120.
   PubMed Web of Science ®Google Scholar
• D SR, K HD, Bandinelli S, et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr. 2010;64(2):203–209.
   PubMed Web of Science ®Google Scholar
• Michaëlsson K, Baron JA, Snellman G, et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr. 2010;92(4):841–848.
   PubMed Web of Science ®Google Scholar
• Hutchinson MS, Grimnes G, Joakimsen RM, et al. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study. Eur J Endocrinol. 2010;162(5):935–942.
   PubMed Web of Science ®Google Scholar
• Virtanen JK, Nurmi T, Voutilainen S, et al. Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland.EUROPEAN. J Nutr. 2011;50(5):305–312.
   Web of Science ®Google Scholar
• Eaton CB, Young A, Allison MA, et al. Prospective association of vitamin D concentrations with mortality in postmenopausal women: results from the Women’s Health Initiative (WHI). Am J Clin Nutr. 2011;94(6):1471–1478.
   PubMed Web of Science ®Google Scholar
• Kestenbaum B, Katz R, de Boer I, et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol. 2011;58(14):1433–1441.
   PubMed Web of Science ®Google Scholar
• Liu L, Chen M, Hankins SR, et al. Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults. Am J Cardiol. 2012;110(6):834–839.
   PubMed Web of Science ®Google Scholar
• Welsh P, Doolin O, McConnachie A, et al. Circulating 25OHD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: the MIDSPAN Family Study. J Clin Endocrinol Metab. 2012;97(12):4578–4587.
   PubMed Web of Science ®Google Scholar
• Kritchevsky SB, Tooze JA, Neiberg RH, et al. 25-Hydroxyvitamin D, parathyroid hormone, and mortality in black and white older adults: the health ABC study. J Clin Endocrinol Metab. 2012;97(11):4156–4165.
   PubMed Web of Science ®Google Scholar
• Messenger W, M NC, Li H, et al. Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr Metab Cardiovasc Dis. 2012;22(10):856–863.
   PubMed Web of Science ®Google Scholar
• de Boer IH, Levin G, Robinson-Cohen C, et al. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Ann Intern Med. 2012;156(9):627–634.
   PubMed Web of Science ®Google Scholar
• Karakas M, Thorand B, Zierer A, et al. Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA/KORA Augsburg case-cohort study. J Clin Endocrinol Metab. 2013;98(1):272–280.
   PubMed Web of Science ®Google Scholar
• Formiga F, Ferrer A, Megido MJ, et al. Low serum vitamin D is not associated with an increase in mortality in oldest old subjects: the Octabaix three-year follow-up study. Gerontology. 2014;60(1):10–15.
   PubMed Web of Science ®Google Scholar
• Robinson-Cohen C, Hoofnagle AN, Ix JH, et al. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA J Am Med Assoc. 2013;310(2):179–188.
   PubMed Web of Science ®Google Scholar
• Schöttker B, Haug U, Schomburg L, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr. 2013;97(4):782–793.
   PubMed Web of Science ®Google Scholar
• Perna L, Schöttker B, Holleczek B, et al. Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: a prospective study with repeated measurements. J Clin Endocrinol Metab. 2013;98(12):4908–4915.
   PubMed Web of Science ®Google Scholar
• Kühn T, Kaaks R, Teucher B, et al. Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European prospective investigation into cancer and nutrition (EPIC)-Germany study. PloS one. 2013;8(7):e69080.
   PubMed Web of Science ®Google Scholar
• Bajaj A, Stone KL, Peters K, et al. Circulating vitamin D, supplement use, and cardiovascular disease risk: the MrOS Sleep Study. J Clin Endocrinol Metab. 2014;99(9):3256–3262.
   PubMed Web of Science ®Google Scholar
• Khaw KT, Luben R, Wareham N. Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: a 13-y prospective population study. Am J Clin Nutr. 2014;100(5):1361–1370.
   PubMed Web of Science ®Google Scholar
• Bansal N, Zelnick L, Robinson-Cohen C, et al. Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2014;3(6):e001278.
   PubMed Web of Science ®Google Scholar
• Chien KL, Hsu HC, Chen PC, et al. Total 25-hydroxyvitamin D concentration as a predictor for all-cause death and cardiovascular event risk among ethnic Chinese adults: a cohort study in a Taiwan community. PloS one. 2015;10(3):e0123097.
   PubMed Web of Science ®Google Scholar
• Michos ED, Misialek JR, Selvin E, et al. 25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: the ARIC study. ATHEROSCLEROSIS. 2015;241(1):12–17.
   PubMed Web of Science ®Google Scholar
• Vitezova A, Cartolano NS, Heeringa J, et al. Vitamin D and the risk of atrial fibrillation–the Rotterdam Study. PloS one. 2015;10(5):e0125161.
   PubMed Web of Science ®Google Scholar
• Nargesi AA, Heidari B, Esteghamati S, et al. Contribution of vitamin D deficiency to the risk of coronary heart disease in subjects with essential hypertension. ATHEROSCLEROSIS. 2016;244:165–171.
   PubMed Web of Science ®Google Scholar
• El Hilali J, de Koning EJ, van Ballegooijen AJ, et al. Vitamin D, PTH and the risk of overall and disease-specific mortality: results of the longitudinal aging study Amsterdam. J Steroid Biochem Mol Biol. 2016;164:386–394.
   PubMed Web of Science ®Google Scholar
• Qi L, Ma W, Heianza Y, et al. Independent and synergistic associations of biomarkers of Vitamin D status with risk of coronary heart disease. ARTERIOSCLEROSIS THROMBOSIS and Vasc Biol. 2017;37(11):2204–2212.
   PubMed Web of Science ®Google Scholar
• Costanzo S, De CA, Di Castelnuovo A, et al. Serum vitamin D deficiency and risk of hospitalization for heart failure: prospective results from the Moli-sani study. Nutr Metab Cardiovasc Dis. 2018;28(3):298–307.
   PubMed Web of Science ®Google Scholar
• Zhu K, Knuiman M, Divitini M, et al. Serum 25-hydroxyvitamin D as a predictor of mortality and cardiovascular events: a 20-year study of a community-based cohort. Clin Endocrinol (Oxf). 2018;88(1):154–163.
   PubMed Web of Science ®Google Scholar
• Wan Z, Guo J, Pan A, et al. Association of serum 25-hydroxyvitamin D concentrations with all-cause and cause-specific mortality Among individuals with diabetes. DIABETES CARE. 2021;44(2):350–357.
   PubMed Web of Science ®Google Scholar
• Fan X, Wang J, Song M, et al. Vitamin D status and risk of all-cause and cause-specific mortality in a large cohort: results from the UK biobank. J Clin Endocrinol Metab. 2020;105(10):dgaa432.
   Web of Science ®Google Scholar
• Lu Q, Wan Z, Guo J, et al. Association between serum 25-hydroxyvitamin D concentrations and mortality among adults with prediabetes. J Clin Endocrinol Metab. 2021;106(10):e4039–e4048.
   PubMed Web of Science ®Google Scholar
• Dudenkov DV, Mara KC, Maxson JA, et al. Serum 25-hydroxyvitamin D values and risk of incident cardiovascular disease: a population-based retrospective cohort study. J Steroid Biochem Mol Biol. 2021;213:105953.
   PubMed Web of Science ®Google Scholar
• Zhu A, Kuznia S, Niedermaier T, et al. Vitamin D-binding protein, total, “nonbioavailable,” bioavailable, and free 25-hydroxyvitamin D, and mortality in a large population-based cohort of older adults. J Intern Med. 2022;292(3):463–476.
   PubMed Web of Science ®Google Scholar
• Zhang P, Guo D, Xu B, et al. Association of serum 25-hydroxyvitamin D with cardiovascular outcomes and all-cause mortality in individuals with prediabetes and diabetes: results from the UK biobank prospective cohort study. DIABETES CARE. 2022;45(5):1219–1229.
   PubMed Web of Science ®Google Scholar
• Sokol SI, Tsang P, Aggarwal V, et al. Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol Rev. 2011;19(4):192–201.
   PubMed Web of Science ®Google Scholar
• Grandi NC, Breitling LP, Brenner H. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med. 2010;51(3–4):228–233.
   PubMed Web of Science ®Google Scholar
• Wang L, Song Y, Manson JE, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5(6):819–829.
   PubMed Web of Science ®Google Scholar
• Acharya P, Dalia T, Ranka S, et al. The effects of Vitamin D supplementation and 25-Hydroxyvitamin D levels on the risk of myocardial infarction and mortality. J Endocr Soc. 2021;5(10):bvab124.
   PubMed Web of Science ®Google Scholar
• Zhou A, Selvanayagam JB, Hyppönen E. Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk. Eur Heart J. 2022;43(18):1731–1739.
   PubMed Web of Science ®Google Scholar
• Dawson-Hughes B, Staten MA, Knowler WC, et al. Intratrial exposure to Vitamin D and new-onset diabetes among adults with prediabetes: a secondary analysis from the Vitamin D and Type 2 diabetes (D2d) study. Diabetes Care. 2020;43(12):2916–2922.
   PubMed Web of Science ®Google Scholar
• Barbarawi M, Kheiri B, Zayed Y, et al. Vitamin D supplementation and cardiovascular disease risks in more than 83 000 individuals in 21 randomized clinical trials: a meta-analysis. JAMA Cardiol. 2019;4(8):765–776.
   PubMed Web of Science ®Google Scholar
• Huang T, Afzal S, Yu C, et al. Vitamin D and cause-specific vascular disease and mortality: a Mendelian randomisation study involving 99,012 Chinese and 106,911 European adults. BMC Med. 2019;17(1):160.
   PubMed Web of Science ®Google Scholar
• Scragg. Limitations of vitamin D supplementation trials: why observational studies will continue to help determine the role of vitamin D in health. J Steroid Biochem Mol Biol. 2018;177:6–9.
   PubMed Web of Science ®Google Scholar
• Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147(12):5542–5548.
   PubMed Web of Science ®Google Scholar
• Peng X, Hawthorne M, Vaishnav A, et al. 25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture. Breast Cancer Res Treat. 2009;113(1):31–41.
   PubMed Web of Science ®Google Scholar
• Hiemstra T, Lim K. Thadhani R, et al.Vitamin D and atherosclerotic cardiovascular disease. J Clin Endocrinol Metab. 2019 Apr 4;jc.2019–00194.
   Google Scholar
• Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Investig. 2002;110(2):229–238.
   PubMed Web of Science ®Google Scholar
• Uberti F, Lattuada D, Morsanuto V, et al. Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways. J Clin Endocrinol Metab. 2014;99(4):1367–1374.
   PubMed Web of Science ®Google Scholar
• Oz F, Cizgici AY, Oflaz H, et al. Impact of vitamin D insufficiency on the epicardial coronary flow velocity and endothelial function. Coron Artery Dis. 2013;24(5):392–397.
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Lee JH, Milani RV. Vitamin D and cardiovascular disease will it live up to its hype? J Am Coll Cardiol. 2011;58(15):1547–1556.
   PubMed Web of Science ®Google Scholar
• Kheiri B, Abdalla A, Osman M, et al. Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clin Hypertens. 2018;24:9.
   PubMedGoogle Scholar
• Rammos G, Tseke P, Ziakka S, et al. the renin-angiotensin system, and insulin resistance. Int Urol Nephrol. 2008;40(2):419–426.
   PubMed Web of Science ®Google Scholar
• Heston TF. Hypovitaminosis D in hypertension. South Med J. 2010;103(8):723–724.
   PubMed Web of Science ®Google Scholar
• Scragg R. Vitamin D and public health: an overview of recent research on common diseases and mortality in adulthood. Public Health Nutr. 2011;14(9):1515–1532.
   PubMed Web of Science ®Google Scholar